The Verte Opportunity Fund is managed by PI Analytics, LLC, an investment adviser pursuant to an Investment Management Agreement. PI Analytics investment advisory team is led by Dr. Leonard Mills, who has over 30 years of experience and proven success in the asset selection and portfolio management.
Dr. Mills’ prior experience includes senior level positions at the Federal Reserve Bank, Fannie Mae, Wells Fargo Bank, and as an adjunct professor. He earned a B.S. in Mathematics from Hampden-Sydney College and a doctoral in Economics from Tulane University. He is a Chartered Financial Analyst (CFA) and holds the Certificate in Quantitative Finance (CQF).
Dr. Mills spent over 15 years as Head of Portfolio Analytics and Research for Fannie Mae’s direct portfolio which peaked at over $1.5 trillion in assets under management. Dr. Mills and his team of 150 quantitative analysts were responsible for all the proprietary analytics and research underlying all asset selections and portfolio management strategies for the entire portfolio. After leaving Fannie Mae, he was a Principal at Unison Investment Management that managed two funds.
Len founded PI Analytics Investment Adviser in 2016 specializing in alternative, hard-to-value assets. Among accounts managed are its first fund, Verte Capital in 2015, to invest in the emerging cannabis industry. He founded the Verte Opportunity in 2019 to invest in and develop emerging companies impacting Opportunity Zones.
Dr. Nao Gamo is a Associate for the Verte family of funds and the Founder and Chief Executive Officer of NeuroSonics Medical, Inc., a startup company developing novel ultrasound transducers for minimally invasive neurosurgery. She is passionate about connecting the entrepreneurial community and has been recognized as one of 25 RealLIST Connectors 2021 for her Health Tech Entrepreneurs Meetup series. Before becoming an entrepreneur, Dr. Gamo spent 15 years as an academic researcher in neuroscience and psychiatry, with a focus on the molecular and cellular mechanisms underlying cognitive impairment related to psychiatric disorders. She completed undergraduate degrees in Brain and Cognitive Sciences and Music from the Massachusetts Institute of Technology, a PhD in Neurobiology from Yale University, and a postdoctoral fellowship in the Molecular Psychiatry Program at the Johns Hopkins University.
VERTE OPPORTUNITY FUND, INC IS A QUALIFIED OPPORTUNITY FUND
DISCLAIMER
Articles featured on this page are for informational purposes only. This is not an offer to sell nor a solicitation to buy Verte Qualified Opportunity Funds. That can only be done by our current Confidential Private Placement Memorandum (“CPPM”). Securities offered by Verte Opportunity Fund Inc. For accredited Investors only. Limited liquidity. The shares being sold in this offering have not been approved or disapproved by the Securities and Exchange Commission or any state’s securities division. Nor has the Securities and Exchange Commission or any state securities department passed upon the accuracy or adequacy of the CPPM or the disclosures provided therein. Any representation to the contrary is a criminal offense. The information contained in this website is for general information purposes only. The information is provided by Verte Opportunity Fund Inc. and while we endeavor to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.